Stephen has spent the past three years at the Vermont Center on Behavioral and Health as a research assistant on Dr. Sigmon’s Interim Buprenorphine Treatment clinical trials, investigating technology-assisted medication delivery to reduce illicit opioid use and other risk behaviors. Prior to coming to the UVM Center on Rural Addiction, they worked as a Lab Technician III for a Developmental Neuroscience Lab in the Department of Brain & Cognitive Sciences at the University of Rochester. Stephen also led a team of sterile compounding technicians in USP797 High Risk and USP800 Hazardous Drug Compounding cleanrooms for four years.
Stephen Crosswhite, BS
